首页> 外国专利> Alfavbeta3 Integrin Inhibitors, a process for their preparation, medicinal products based on these Compounds, Pharmaceutical compositions containing them and Use thereof for preparing a Medicine to fight diseases that are based on the expression and function.

Alfavbeta3 Integrin Inhibitors, a process for their preparation, medicinal products based on these Compounds, Pharmaceutical compositions containing them and Use thereof for preparing a Medicine to fight diseases that are based on the expression and function.

机译:Alfavbeta3整联蛋白抑制剂,其制备方法,基于这些化合物的药用产品,含有它们的药物组合物及其在制备抗表达和功能性疾病的药物中的用途。

摘要

Describes the alfavbeta3 Integrin inhibitors of formula (1): X - y - Z - CH2 - R2 (R1 - R4 R5) - CH2 - CO, where X means: H2n - C (= NH) H2n -, - C (= NH) - NH, - C (= NH het1) - NH -, - or het1 - NH -, where the primary amino groups can also be fitted with conventional amino Protecting groups; and S Means N - (CH2), or a compound of formula (2) for 1, 2,3 or 4 methylene Group can be replaced by N, and / or s; Z is absent or means - or -, - NH -, na -, - ch - ch (OH) (OA), cha, Ca2 - or - S - phenylene R1 does not; replaced or substituted 1, 2 or 3 times with F, CL, BR, CN, OA, or ocf3; R2 is n, CH or CA; R3 is H, F, CL, B R, a, AB or ocf3 means; R4 phenyl, naphthyl, or het2 unsubstituted or substituted with one or several times,Aryl or Cf3; R5 oa means, NH2, Oh, Nha or NA2; het1 means a Heterocycles 1 or 2 cores with one to four n ATOMS, which can not be replaced or substituted 1 - 2 times with NH2; het2 means a Heterocyclic Aromatic Nuclei with 1 to 1 or 2 3 Atoms of N or and / or s, which may be not 1 or 2 Times replaced or substituted with F, CL, BR, or SA, ocf3, co, CN, CONH2 conha COOA,,,Cona2 or NO2; aryl phenyl substituted or unsubstituted means 1, 2 or 3 times with Hal, or oa means C1 - 12; alkyl; n is 1 to 12; M and mean or independently from 1 to 12; and their Salts and solvates physiologically harmless.These compounds inhibit the interaction of the Receptor with the ligand alfav, being especially effective as alfavbeta3 Integrin ligands.Also described is a process for preparing compounds of formula (1), drugs containing these Compounds, Pharmaceutical compositions containing them and Use thereof for the preparation of a drug to combat diseases that are based on the expression The Function and the Pathological alfavbeta3 Integrin Receptors, in particular,To combat the thrombosis, myocardial infarction, coronary heart disease, arteriosclerosis, Tumors, osteoporosis, fibrosis, inflammation, Infections, lapsoriasis, so as to influence the processes of Wound Healing.
机译:描述式(1)的alfavbeta3整联蛋白抑制剂:X-y-Z-CH2-R2(R1-R4 R5)-CH2-CO,其中X表示:H2n-C(= NH)H2n-,-C(= NH )-NH,-C(= NH het1)-NH-,-或het1- NH-,其中伯氨基也可与常规氨基保护基团配合; S表示N-(CH 2),或用于1、2、3或4个亚甲基的式(2)化合物可以被N和/或s取代; Z不存在或表示-或-,-NH-,na-,-ch-ch(OH)(OA),cha,Ca2-或-S-亚苯基R1没有;用F,CL,BR,CN,OA或ocf3取代或取代1、2或3次; R2为n,CH或CA; R3是H,F,CL,BR,a,AB或ocf3的意思; R4未取代或被一或几次芳基或Cf3取代的苯基,萘基或het2; R 5 a表示NH 2,Oh,Nha或NA 2; het1表示具有1至4个n ATOMS的杂环1或2个核,不能被NH2取代或替代1-2次; het2表示具有1个或1个或2个3个N或和 /或s原子的杂环芳香核,它可能不是用F,CL,BR或SA,ocf3,co,CN, CONH2 conha COOA 、、 Cona2或NO2;取代或未取代的芳基苯基用Hal表示1、2或3次,或oa表示C1-12;烷基; n为1至12; M为均数或独立于1至12;这些化合物抑制受体与alfav配体的相互作用,特别是作为alfavbeta3整联蛋白配体有效。含有它们的药物及其在制备抗疾病药物中的用途,这些药物基于以下表达:功能和病理学alfavbeta3整合素受体,特别是用于对抗血栓形成,心肌梗塞,冠心病,动脉硬化,肿瘤,骨质疏松症,纤维化,炎症,感染,牛皮癣,从而影响伤口愈合的过程。

著录项

  • 公开/公告号AR034692A1

    专利类型

  • 公开/公告日2004-03-17

    原文格式PDF

  • 申请/专利号AR2000P104353

  • 申请日2000-08-23

  • 分类号C07D213/74;C07D233/88;C07D239/42;C07D333/48;C07D409/12;C07D521/00;A61K31/4184;A61K31/4168;A61K31/44;A61K31/4402;A61K31/505;A61P7/00;A61P7/02;A61P7/04;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P17/00;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P19/04;A61P19/10;A61P27/00;A61P27/06;A61P27/10;A61P29/00;A61P31/04;A61P31/10;A61P31/12;A61P35/00;A61P35/04;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号